学術雑誌論文 A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head.

Kuroda, Yutaka  ,  Asada, Ryuta  ,  So, Kazutaka  ,  Yonezawa, Atsushi  ,  Nankaku, Manabu  ,  Mukai, Kumi  ,  Ito-Ihara, Toshiko  ,  Tada, Harue  ,  Yamamoto, Michio  ,  Murayama, Toshinori  ,  Morita, Satoshi  ,  Tabata, Yasuhiko  ,  Yokode, Masayuki  ,  Shimizu, Akira  ,  Matsuda, Shuichi  ,  Akiyama, Haruhiko

40 ( 8 )  , pp.1747 - 1754 , 2015-12-29 , Springer Berlin Heidelberg
ISSN:0341-2695
NII書誌ID(NCID):AA0068148X
内容記述
特発性大腿骨頭壊死症に対する再生医療の良好な結果. 京都大学プレスリリース. 2016-02-02.
We evaluated the safety and clinical outcomes of a single local administration of gelatin hydrogel impregnated with recombinant human fibroblast growth factor (rhFGF)-2 for the treatment of the precollapse stage of osteonecrosis of the femoral head (ONFH).
本文を読む

http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/204075/1/s00264-015-3083-1.pdf

このアイテムのアクセス数:  回

その他の情報